在小鼠中由同源重组缺陷引发的脑髓母细胞瘤
Huimei Lu1, Yuan Wang1, Shipra Chaudhary1
1Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey; Department of Radiation Oncology, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.
The American journal of pathology
|August 21, 2024
概括
像Brca1和Palb2这样的同源重组 (HR) 基因中的生殖系突变可以在小鼠中启动脑髓母细胞瘤. 这些瘤对PARP抑制剂表现出敏感性,提供了新的治疗途径.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 同类重组 (HR) 基因中的生殖系突变是脑髓母细胞瘤的关键驱动因素.
- 基因组分析显示,在很大一部分人脑髓母细胞瘤中存在HR缺陷.
研究的目的:
- 研究Brca1,Brca2,Palb2和Bccip基因切除在小鼠脑髓母细胞瘤发作中的差异性作用.
- 建立和描述用于研究HR缺陷性脑髓母细胞瘤的新型小鼠模型.
主要方法:
- 为Brca1,Brca2和Palb2生成了条件淘汰赛小鼠模型.
- 在小鼠大脑中确定了Bccip (shBccip-KD) 的条件淘汰.
- 进行了Trp53共删除,以评估其对脑髓母细胞瘤发展的影响.
主要成果:
- 删除Brca1,Brca2或Palb2,特别是与Trp53共删除,诱导了髓母细胞瘤.
- Brca1和Bccip缺乏导致严重的小头和神经缺陷.
- 来自brca1,palb2和brca2缺乏的小鼠的骨髓母细胞瘤对多 (adp-ribose) 聚合酶抑制剂有反应,与shBccip-KD小鼠的不同.
结论:
- Brca1和Palb2的无活化与Trp53的缺失是小鼠脑髓母细胞瘤的强有力的诱导剂.
- 开发的小鼠模型准确地回顾了脑髓母细胞瘤的发展,对治疗剂的测试有价值.
- 对PARP抑制剂的敏感性可以区分HR缺陷髓母细胞瘤,指导向治疗策略.
相关概念视频
Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
In-vitro Mutagenesis
13.9K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
13.9K


